{"id":34,"date":"2025-09-25T14:12:07","date_gmt":"2025-09-25T14:12:07","guid":{"rendered":"https:\/\/draft.lyomark.com\/?page_id=34"},"modified":"2026-05-01T07:17:33","modified_gmt":"2026-05-01T07:17:33","slug":"company","status":"publish","type":"page","link":"https:\/\/lyomark.com\/en\/unternehmen\/","title":{"rendered":"Company"},"content":{"rendered":"
\n
\n
\n

Company<\/h1>\n\n\n\n
\n\n\n\n

Since its founding in 1989, Lyomark Pharma has become an experienced and reliable partner to the pharmaceutical industry.<\/h2>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
<\/path><\/svg><\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n

About Us<\/h3>\n\n\n\n

Through many years of extensive experience in all areas of pharmaceuticals \u2013 from manufacturing to sales \u2013 Lyomark has developed into an experienced and reliable partner for the pharmaceutical industry!<\/p><\/blockquote><\/figure>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n

Lyomark Pharma was founded in 1989 as a contract manufacturer of active pharmaceutical ingredients and finished products for niche markets in Oberhaching, near Munich. As the name suggests, Lyomark is a service provider for lyophilised and liquid sterile products and has established itself in this sector of the pharmaceutical industry for over 25 years.<\/p>\n\n\n\n

Services for pharmaceutical clients include manufacturing, as well as the provision and maintenance of dossiers and the submission of national and international approvals for well-known pharmaceutical companies.<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\n

Philosophy<\/h3>\n\n\n\n

Customer focus combined with outstanding service quality will always be the company's top priority.<\/p><\/blockquote><\/figure>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n

The philosophy of the medium-sized company is to accept and master national and international challenges in all areas \u2013 from production to sales. Lyomark Pharma's recipe for success lies in remaining flexible at all times and being able to react immediately to changing market conditions while complying with the ever-increasing regulatory framework.<\/p>\n\n\n\n

Through this philosophy, the medium-sized company has achieved constant development and steady growth in recent years. Every Lyomark Pharma employee is aware of their individual influence on business success. Customer focus, combined with high service quality, is and remains the company's top priority.<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\n

Team<\/h3>\n\n\n\n

We see Lyomark's culture as a competitive advantage and strive to create an environment where smart, motivated and creative people can thrive.<\/p><\/blockquote><\/figure>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n

Behind our products, solutions, and services is a team of professionals with extensive experience and knowledge in the pharmaceutical sector. Our employees are dedicated team players, bringing energy, ideas and pride to their work.<\/p>\n\n\n\n

Since 1 October 2021, Dr Wolfgang Burger has taken over the management. Dr Burger has over 30 years of experience in the pharmaceutical industry, most recently as Managing Director of PharmaZell GmbH.<\/p>\n\n\n\n

With effect from 1st April 2022, Dr. Dirk H\u00fctten has joined Mr. Dr. Burger on the management board. Dr. H\u00fctten has over 20 years of experience in various international sales roles along the pharmaceutical product supply chain.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
<\/path><\/svg><\/div>\n<\/div>\n\n\n\n
\n
\n

Milestones<\/h3>\n\n\n\n
\n
\n

Integration of Lyomark Pharma as a service provider for the manufacture of Edelfosine.<\/p>\n<\/div>

<\/i><\/div>

1998<\/p><\/div><\/div><\/div>\n\n\n\n

\n

In November, Dr. Helmut Wolf will become Chief Executive Officer.<\/p>\n<\/div>

<\/i><\/div>

1994<\/p><\/div><\/div><\/div>\n\n\n\n

\n

Extension for a contract manufacturing service provider for sterile
Products with somatostatin as the first product.<\/p>\n<\/div>

<\/i><\/div>

1995<\/p><\/div><\/div><\/div>\n\n\n\n

\n

Development of Octreotide.<\/p>\n<\/div>

<\/i><\/div>

2001<\/p><\/div><\/div><\/div>\n\n\n\n

\n

Vancomycin development.<\/p>\n<\/div>

<\/i><\/div>

2002<\/p><\/div><\/div><\/div>\n\n\n\n

\n

Submission of international registrations for Lyomark generics.<\/p>\n<\/div>

<\/i><\/div>

2003<\/p><\/div><\/div><\/div>\n\n\n\n

\n

International sales partner for medicinal products and active ingredients.<\/p>\n<\/div>

<\/i><\/div>

2005<\/p><\/div><\/div><\/div>\n\n\n\n

\n

Acquisition of Alveofact\u00ae from Boehringer Ingelheim.<\/p>\n\n\n\n

Founding of the sister company Bendalis GmbH.<\/p>\n<\/div>

<\/i><\/div>

2006<\/p><\/div><\/div><\/div>\n\n\n\n

\n

Establishment of your own sales organisation in Germany.<\/p>\n<\/div>

<\/i><\/div>

2007<\/p><\/div><\/div><\/div>\n\n\n\n

\n

International registrations for Alveofact\u00ae.<\/p>\n<\/div>

<\/i><\/div>

2009<\/p><\/div><\/div><\/div>\n\n\n\n

\n

Approval of Ciprofloxacin, Levofloxacin and Fluconazole.<\/p>\n<\/div>

<\/i><\/div>

2014<\/p><\/div><\/div><\/div>\n\n\n\n

\n

Approval of NeoKay\u00ae in Germany.<\/p>\n<\/div>

<\/i><\/div>

2016<\/p><\/div><\/div><\/div>\n\n\n\n

\n

Acquisition of a majority stake in LYOCONTRACT.<\/p>\n<\/div>

<\/i><\/div>

2017<\/p><\/div><\/div><\/div>\n

<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
<\/path><\/svg><\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n

Quality Management<\/h3>\n\n\n\n

We will gladly provide you with information on our quality policy upon request.<\/p><\/blockquote><\/figure>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n

Lyomark Pharma GmbH places great importance on quality.<\/p>\n\n\n\n

With GMP and GDP certification, as well as a manufacturing and wholesale licence, we meet all expectations for the production and distribution of our products.<\/p>\n\n\n\n

This means all our customers and stakeholders can rely on Lyomark Pharma's quality standards.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
<\/path><\/svg><\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n

Our sister company, Bendalis GmbH, was founded in 2006 and specialises in the development and marketing of high-quality oncology medicines for the treatment of cancer.<\/p>\n\n\n\n

As a company with global operations, based in Germany, we see it as our responsibility to provide our customers with products of impeccable quality, manufactured to European quality standards.<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\"Bendalis<\/a><\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Unternehmen Seit der Gr\u00fcndung 1989 hat sich Lyomark Pharma zu einem erfahrenen und verl\u00e4sslichen Partner der pharmazeutischen Industrie entwickelt. \u00dcber uns Durch die langj\u00e4hrige und umfassende Erfahrung in s\u00e4mtlichen pharmazeutischen Bereichen \u2013 von der Herstellung bis zum Vertrieb \u2013 hat sich Lyomark zum erfahrenen und verl\u00e4sslichen Partner der pharmazeutischen Industrie entwickelt! Lyomark Pharma wurde im […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-no-title","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":""},"class_list":["post-34","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/pages\/34","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/comments?post=34"}],"version-history":[{"count":148,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/pages\/34\/revisions"}],"predecessor-version":[{"id":5276,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/pages\/34\/revisions\/5276"}],"wp:attachment":[{"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/media?parent=34"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}